Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers

Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from

GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer

Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

Programming the immunological properties of mRNA vaccines for cancer